TA216 Leukaemia (lymphocytic) - bendamustine: Appendix A - provisional matrix of stakeholders
TA216 Leukaemia (lymphocytic) - bendamustine: Appendix A - provisional matrix of stakeholders
20 December 2013 (99.62 Kb 29 sec) |
This page was last updated: 16 December 2013